
Sign up to save your podcasts
Or
Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure. You won’t want to miss part 2 of this interview!
Produced by Susan Quirk and Amber Roniger
Support the show
4.7
1414 ratings
Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure. You won’t want to miss part 2 of this interview!
Produced by Susan Quirk and Amber Roniger
Support the show
7,225 Listeners
12,592 Listeners
110,822 Listeners
10,137 Listeners
3,478 Listeners
9,285 Listeners
3,722 Listeners
8,220 Listeners
6,004 Listeners
12,872 Listeners
15,488 Listeners
19,449 Listeners
10,631 Listeners
10,742 Listeners
306 Listeners